Combination of interferon (IFN) induction therapy and ribavirin in chronic hepatitis C.

被引：2
|
作者：
Ferenci, P
Brunner, H
Vogel, W
Gschwantler, M
Datz, C
Hackl, F
Steindl-Munda, PE
Hofer, H
Mueller, C
Mueller, C
机构：
[1] Univ Vienna, Vienna, Austria
[2] Hosp Lainz, Vienna, Austria
[3] Univ Innsbruck, Vienna, Austria
[4] Hosp Rudolfsstiftung, Vienna, Austria
[5] St Johann Hosp, Salzburg, Austria
[6] St Elizabeth Hosp, Linz, Austria
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)85986-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
977
引用
收藏
页码：A961 / A961
页数：1
相关论文
共 50 条
  • [41] Combination therapy with interferon-α and ribavirin as immunomodulators in patients with chronic hepatitis C
    Norio Horiike
    Morikazu Onji
    Journal of Gastroenterology, 2003, 38 : 302 - 304
  • [42] Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C
    McHutchison, JG
    Poynard, T
    SEMINARS IN LIVER DISEASE, 1999, 19 : 57 - 65
  • [43] Effect of lactoferrin in patients with chronic hepatitis C: Combination therapy with interferon and ribavirin
    Kaito, Masahiko
    Iwasa, Motoh
    Fujita, Naoki
    Kobayashi, Yoshinao
    Kojima, Yuji
    Ikoma, Jiro
    Imoto, Ichiro
    Adachi, Yukihiko
    Hamano, Hirokazu
    Yamauchi, Koji
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (11) : 1894 - 1897
  • [44] Interferon α and ribavirin combination therapy in patients with chronic hepatitis C and mixed cryoglobulinemia
    Donada, C
    Crucitti, A
    Donadon, V
    Chemello, L
    Alberti, A
    BLOOD, 1998, 92 (08) : 2983 - 2984
  • [45] Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C
    Iwasaki, Y
    Ikeda, H
    Araki, Y
    Osawa, T
    Kita, K
    Ando, M
    Shimoe, T
    Takaguchi, K
    Hashimoto, N
    Kobatake, T
    Tomita, M
    Kawaguchi, M
    Kobashi, H
    Sakaguchi, K
    Shiratori, Y
    HEPATOLOGY, 2006, 43 (01) : 54 - 63
  • [46] Efficacy and safety of combination therapy with interferon plus ribavirin in HIV-infected patients with chronic hepatitis C.
    Pérez-Olmeda, M
    Romero, M
    Asensi, V
    Sanchez-Montero, R
    Ochoa, A
    García-Samaniego, J
    Soriano, V
    HEPATOLOGY, 2001, 34 (04) : 332A - 332A
  • [47] A comparison of standard and induction interferon therapy with and without initial ribavirin in treatment naive patients with chronic hepatitis C.
    Peine, CJ
    Albrecht, JK
    Roel, JP
    Gundersen, BA
    Kirchner, JP
    Zins, B
    McKee, D
    Ho, SB
    Smith, T
    HEPATOLOGY, 2000, 32 (04) : 364A - 364A
  • [48] Hepatic iron concentration does not predict response to interferon/ribavirin combination therapy in patients with chronic hepatitis C.
    Hofer, H
    Steindl-Munda, P
    Kazemi-Shirazi, L
    Datz, C
    Mueller, C
    Penner, E
    Ferenci, P
    HEPATOLOGY, 1999, 30 (04) : 198A - 198A
  • [49] Combination therapy with interferon and ribavirin for chronic hepatitis C patients resistant to alfa interferon.
    Herrera, J
    HEPATOLOGY, 1998, 28 (04) : 375A - 375A
  • [50] Hematological changes during IFN/ribavirin combination therapy in patients with chronic hepatitis C
    Wichlas, M
    Hofer, H
    Homoncik, M
    Gangl, A
    Ferenci, P
    Peck-Radosavljevic, M
    Kreil, A
    JOURNAL OF HEPATOLOGY, 2002, 36 : 114 - 115
12345